Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares traded 8.33% higher at $1.43 on Wall Street last session.
CYCC stock price is now 34.36% away from the 50-day moving average and -22.11% away from the 200-day moving average. The market capitalization of the company currently stands at $3.07M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
, while ‘Ladenburg Thalmann’ rates the stock as ‘Buy’
In other news, McBarron Paul, insider bought 1,886 shares of the company’s stock on Dec 21 ’23. The stock was bought for $6,252 at an average price of $3.31. Upon completion of the transaction, the insider now directly owns 33,378 shares in the company, valued at $47730.54. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 21 ’23, President and CEO Rombotis Spiro George bought 6,070 shares of the business’s stock. A total of $20,122 was incurred on buying the stock at an average price of $3.31. This leaves the insider owning 68,658 shares of the company worth $98180.94. A total of 4.50% of the company’s stock is owned by insiders.
During the past 12 months, Cyclacel Pharmaceuticals Inc has had a low of $0.75 and a high of $10.12. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 1.07, and a quick ratio of 1.07. The fifty day moving average price for CYCC is $1.063 and a two-hundred day moving average price translates $1.8413 for the stock.
The latest earnings results from Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) was released for 2024-06-30. The net profit margin was -22007.50% and return on equity was -329.40% for CYCC. The company reported revenue of $4000.0 for the quarter, compared to $0.37 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -98.93 percent.
